文献速递胃肠外科围术期管理与 ERAS

非治愈性内镜黏膜下剥离对pT1胃癌后续腹腔镜胃切除术短期和长期结局的影响

Impact of non-curative endoscopic submucosal dissection on short- and long-term outcome of subsequent laparoscopic gastrectomy for pT1 gastric cancer.
PubMed 文献 · Surg Endosc · 2021-09-07

经倾向性评分匹配后各75例比较,发现两组术后并发症、死亡率及5年总生存率和疾病特异性生存率均无显著差异,提示术前内镜黏膜下剥离史(包括非治愈性切除)不影响后续腹腔镜胃切除术的肿瘤学和手术结局。

要点

  • 术前内镜黏膜下剥离史不影响pT1早期胃癌腹腔镜胃切除术的短期手术结局。
  • 非治愈性内镜黏膜下剥离后行腹腔镜胃切除术的5年生存率与直接手术者相当。
  • 对pT1早期胃癌,即使内镜黏膜下剥离为非治愈性切除,术前内镜治疗仍可行。

核心结论

  • pT1早期胃癌患者腹腔镜胃切除术的短期和长期结局与术前是否行内镜黏膜下剥离无关。
  • 即使内镜黏膜下剥离为非治愈性切除,术前内镜治疗在肿瘤学和手术结局方面仍是可行的。

研究设计与样本

  • 采用倾向性评分匹配性别、年龄、体重指数、美国麻醉医师协会评分、腹部手术史、肿瘤位置、黏膜/黏膜下浸润、组织学、淋巴结转移、淋巴结清扫范围、手术方式、淋巴管侵犯和静脉侵犯后比较两组资料。
  • 匹配后非内镜黏膜下剥离组和内镜黏膜下剥离组各75例。
  • 中位随访60个月(范围2-168个月)。

主要发现

  • 匹配后两组特征和临床病理结果无显著差异。
  • 术后并发症发生率分别为13.3%和17.3%(P=0.497),无显著差异。
  • 术后死亡率分别为1.3%和0%(P=0.316),无显著差异。
  • 5年总生存率分别为88.8%和86.9%(P=0.757),无显著差异。
  • 5年疾病特异性生存率分别为97.1%和98.4%(P=0.333),无显著差异。

临床怎么用

  • 对于pT1早期胃癌,术前曾行内镜黏膜下剥离(包括非治愈性切除)不应被视为后续腹腔镜胃切除术的禁忌。
  • 临床决策时可参考本研究结果,但需结合患者个体情况和多学科讨论。

局限性

  • 单中心回顾性研究,可能存在选择偏倚。
  • 匹配后每组样本量较小(各75例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The feasibility and oncological safety of non-curative endoscopic submucosal dissection (ESD) prior to additional gastrectomy for early gastric cancer (EGC) are still unclear. The aim of this study was to evaluate the impact of non-curative ESD on short- and long-term outcomes of subsequent laparoscopic gastrectomy (LG) for pathological T1 (pT1) EGC. METHODS: We retrospectively investigated 422 patients who underwent LG for pT1 EGC between January 2007 and December 2017 at our center. Eighty-five of these patients underwent ESD with curative intent before surgery. Using propensity-score matching for sex, age, body mass index, American society of anesthesiologists score, history of previous abdominal surgery, tumor location, mucosal/submucosal infiltration, histology, lymph node metastasis, extent of lymph node dissection, operative method, lymphatic invasion, and venous invasion, the clinicopathologic and survival data of these patients were compared. RESULTS: The median follow-up period was 60 (range 2-168) months. Using propensity-score matching from a total of 422 patients, 75 patients were selected in the Non-ESD and the ESD cohorts each. There were no significant differences in terms of characteristics and clinicopathological findings between the two groups. Furthermore, there were no significant differences in postoperative morbidity (13.3% vs. 17.3%; P = 0.497) and mortality (1.3% vs. 0%; P = 0.316). Both the 5-year overall survival ratio (88.8% vs. 86.9%; P = 0.757) and 5-year disease-specific survival ratio (97.1% vs. 98.4%; P = 0.333) were similar in the two groups. CONCLUSION: Short- and long-term outcomes of LG in patients with pT1 EGC are not related to preoperative ESD history. Even for non-curative resections, ESD prior to surgery is feasible in terms of oncological and surgical outcomes in pT1 EGC.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Shimada S, Sawada N, Oae S, et al. Impact of non-curative endoscopic submucosal dissection on short- and long-term outcome of subsequent laparoscopic gastrectomy for pT1 gastric cancer. Surg Endosc. 2021. PMID: 34494156. doi:10.1007/s00464-021-08718-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。